For help on how to get the results you want, see our search tips.
48 results
Keyword Remove keyword
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Authorisation status
Refused Remove Refused filter
-
List item
Human medicine European public assessment report (EPAR): Acrescent
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Adlumiz
anamorelin hydrochloride, Cachexia, Anorexia, Carcinoma, Non-Small-Cell Lung
Date of refusal: 16/11/2017, Refused, Last updated: 30/11/2017 -
List item
Human medicine European public assessment report (EPAR): Alpheon
recombinant human interferon alfa-2a, Hepatitis C, Chronic
Date of refusal: 05/09/2006,
, Refused, Last updated: 28/06/2006
-
List item
Human medicine European public assessment report (EPAR): Alsitek
masitinib mesylate, Amyotrophic Lateral Sclerosis
Date of refusal: 26/07/2018,
, Refused, Last updated: 31/07/2018
-
List item
Human medicine European public assessment report (EPAR): Aplidin
Plitidepsin, Multiple Myeloma
Date of refusal: 17/07/2018,, Refused, Last updated: 01/08/2018
-
List item
Human medicine European public assessment report (EPAR): Balaxur
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Teva
cabazitaxel, Prostatic Neoplasms
Date of refusal: 11/07/2019, Refused, Last updated: 24/07/2019 -
List item
Human medicine European public assessment report (EPAR): Cimzia
Certolizumab pegol, Crohn Disease
Date of refusal: 21/05/2008, Refused, Last updated: 20/03/2008 -
List item
Human medicine European public assessment report (EPAR): Dexxience
betrixaban maleate, Venous Thromboembolism
Date of refusal: 20/09/2018, Refused, Last updated: 09/10/2018 -
List item
Human medicine European public assessment report (EPAR): Doxolipad
doxorubicin hydrochloride, Breast Neoplasms, Ovarian Neoplasms
Date of refusal: 08/08/2019, Refused, Last updated: 26/08/2019 -
List item
Human medicine European public assessment report (EPAR): Dropcys
mercaptamine, Corneal Diseases, Cystinosis
Date of refusal: 24/06/2016,, Refused, Last updated: 25/07/2016
-
List item
Human medicine European public assessment report (EPAR): Eladynos
abaloparatide, Osteoporosis
Date of refusal: 07/01/2019, Refused, Last updated: 14/02/2019 -
List item
Human medicine European public assessment report (EPAR): Elelyso
Taliglucerase alfa, Gaucher Disease
Date of refusal: 25/10/2012,, Refused, Last updated: 23/11/2012
-
List item
Human medicine European public assessment report (EPAR): EnCyzix
enclomifene citrate, Hypogonadism
Date of refusal: 06/04/2018, Refused, Last updated: 26/01/2018 -
List item
Human medicine European public assessment report (EPAR): Exondys
eteplirsen, Muscular Dystrophy, Duchenne
Date of refusal: 06/12/2018,, Refused, Last updated: 12/12/2018
-
List item
Human medicine European public assessment report (EPAR): Fanaptum
iloperidone, Schizophrenia
Date of refusal: 15/01/2018, Refused, Last updated: 19/03/2018 -
List item
Human medicine European public assessment report (EPAR): Folotyn
Pralatrexate, Lymphoma, T-Cell
Date of refusal: 21/06/2012,, Refused, Last updated: 11/07/2012
-
List item
Human medicine European public assessment report (EPAR): Gemesis
becaplermin, Guided Tissue Regeneration, Periodontal
Date of refusal: 29/01/2010, Refused, Last updated: 20/11/2009 -
List item
Human medicine European public assessment report (EPAR): Genasense
oblimersen, Melanoma
Date of refusal: 15/10/2007, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Heparesc
Human heterologous liver cells, Urea Cycle Disorders, Inborn
Date of refusal: 21/12/2015,, Refused, Last updated: 04/04/2016
-
List item
Human medicine European public assessment report (EPAR): Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech
human IgG1 monoclonal antibody specific for human interleukin-1 alpha, Colorectal Neoplasms
Date of refusal: 08/12/2017, Refused, Last updated: 13/11/2017 -
List item
Human medicine European public assessment report (EPAR): Impulsor
milnacipran, Fibromyalgia
Date of refusal: 08/04/2010, Refused, Last updated: 26/04/2010 -
List item
Human medicine European public assessment report (EPAR): Istodax
romidepsin, Lymphoma, Non-Hodgkin
Date of refusal: 12/02/2013,, Refused, Last updated: 14/03/2013
-
List item
Human medicine European public assessment report (EPAR): Kynamro
mipomersen sodium, Hypercholesterolemia
Date of refusal: 29/05/2013, Refused, Last updated: 17/06/2013 -
List item
Human medicine European public assessment report (EPAR): Labazenit
budesonide, salmeterol, Asthma
Date of refusal: 06/09/2013, Refused, Last updated: 22/03/2013